Clinical Trial: A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Randomized, Double Blind, Placebo Controlled, Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome

Brief Summary: To evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndrome.

Detailed Summary:
Sponsor: Kissei Pharmaceutical Co., Ltd.

Current Primary Outcome: Corneal staining score [ Time Frame: 6 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Conjunctival staining score [ Time Frame: 6 weeks ]

Original Secondary Outcome: Same as current

Information By: Kissei Pharmaceutical Co., Ltd.

Dates:
Date Received: September 1, 2011
Date Started:
Date Completion:
Last Updated: October 29, 2013
Last Verified: October 2013